[Form 4] Insulet Corporation Insider Trading Activity

Rhea-AI Filing Summary

Insulet Corporation (PODD) Form 4 shows insider transactions by Laetitia Cousin, SVP, Regulatory, Quality & Compliance, dated 09/08/2025. The filing reports the acquisition of 541 shares via an employee stock option exercisable at $276.36 and 256 shares via a separate option exercisable at $166.62, both effective 09/08/2025. The reporting person also acquired 541 and 256 shares (reported as non-derivative acquisitions) at those prices and sold 797 shares on the same date at a weighted average price of $348.81. The filing discloses that 93 of the acquired shares were purchased under the company stock purchase plan since the last Section 16 filing. Following the reported transactions, beneficial ownership figures are shown as 4,431; 4,687; and 3,890 shares on the respective lines. The transactions include annual non-qualified option awards that vest in four substantially equal annual installments.

Positive

• Option exercises and share acquisitions were executed, increasing the reporting person's stake before the sale (541 and 256 shares acquired via options).
• Employee Stock Purchase Plan participation: 93 shares purchased since the last Section 16 filing, showing continued insider participation in company equity.
• Clear disclosures including exercise prices, sale weighted-average price, and explanatory notes offering per-price sale details on request.

Negative

• Insider sale of 797 shares at a weighted average price of $348.81 reduced reported holdings to as low as 3,890 shares on one line.
• No broader company context is provided in the filing to explain the rationale for the sale, limiting interpretability of insider intent.

Insights

Financial Analyst

TL;DR: Routine insider option exercises, purchases and a partial sale; represents personal rebalancing rather than a clearly material corporate event.

The filing documents standard Section 16 activity: option grants becoming exercisable and exercises at strike prices of $276.36 and $166.62, concurrent non-derivative acquisitions, and a sale of 797 shares at a weighted average of $348.81. The inclusion of 93 shares from the Employee Stock Purchase Plan is disclosed. These actions alter the reporting person’s direct holdings (reported on separate lines as 4,431; 4,687; and 3,890 shares) but do not, by themselves, disclose any company-level operational or financial change. For investors, this is useful for tracking insider ownership and timing of option exercises, but it is routine in nature and does not indicate a material change to Insulet’s capital structure or operations.

Corporate Governance Expert

TL;DR: Compliance appears complete: Form 4 reports option awards, exercises, ESPP purchases and a sale with explanatory notes.

The Form 4 includes clear disclosures: transaction codes, exercise prices, weighted-average sale price range, and an explanatory note committing to provide per-price sale details if requested. The filing identifies the reporting person’s role and uses attorney-in-fact signature. The presence of annual non-qualified option awards with four-year vesting is documented. From a governance perspective, the form meets disclosure norms under Section 16; no governance issues or exceptions are reported within the filing text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cousin Laetitia

(Last) (First) (Middle)

C/O INSULET CORPORATION

100 NAGOG PARK

(Street)

ACTON MA 01720

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSULET CORP [ PODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Reg, Quality & Compliance

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2025		M		541	A	$276.36	4,431(1)	D
Common Stock	09/08/2025		M		256	A	$166.6	4,687	D
Common Stock	09/08/2025		S		797	D	$348.81(2)	3,890	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$276.36	09/08/2025		M			541	(3)	02/28/2033	Common Stock	541	$0	542	D
Stock Option (Right to Buy)	$166.62	09/08/2025		M			256	(3)	02/27/2034	Common Stock	256	$0	3,876	D

Explanation of Responses:

1. Includes 93 shares acquired under the Insulet Corporation Stock Purchase Plan since the date of the Reporting Person's last Section 16 filing.

2. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $348.40 to $348.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

3. Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

	/s/ Patricia K. Dolan, attorney-in-fact	09/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Laetitia Cousin report on Form 4 for PODD?

The Form 4 reports acquisition of 541 shares via an option exercisable at $276.36, acquisition of 256 shares via an option exercisable at $166.62, and a sale of 797 shares at a weighted average price of $348.81 on 09/08/2025.

How many shares did the reporting person own after the transactions?

The filing lists beneficial ownership figures of 4,431, 4,687, and 3,890 shares on the respective reported lines following the transactions.

Were any of the shares acquired through a company plan?

Yes. The filing discloses 93 shares acquired under the Insulet Corporation Stock Purchase Plan since the last Section 16 filing.

What prices applied to the option exercises and sale?

Option exercise prices are $276.36 and $166.62. The sale price reported is a weighted average of $348.81, with individual sale prices in the range $348.40 to $348.93.

Are the option grants subject to vesting conditions?

Yes. The filing states the annual non-qualified stock options vest in substantially equal installments on each of the first four anniversaries of the grant date.